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ABSTRACT
International Journal of Exercise Science 14(2): 250-259, 2021. Several recent reports have indicated

positive health and exercise benefits of (-)-epicatechin-rich cocoa products. This study investigated the influence of
dark chocolate (DC) supplementation on resting and steady state exercise metabolism in a group of athletically fit
females. Using a randomized, single-blind design, 18 exercise trained female subjects were assigned to a 30-d
supplementation with either 20g· d-1 of 70% DC (n = 9) or a calorically matched white chocolate (WC) (n = 9). Presupplementation (PRE), subjects underwent indirect calorimetry assessment for resting energy expenditure (REE)
and exercise energy expenditure (EEE) consisting of steady state cycling for 20 min, 10 min each at 50 W (EEE-50)
and 100 W (EEE-100). Upon completion of the 30-d supplementation (POST), subjects repeated the assessment for
REE, EEE-50, and EEE-100. Post supplementation REE was significantly increased by ~9.6% in the DC group (Δ
REE: DC 140 ± 132, WC -3 ± 92 kcal· d-1, p = .017). Post supplementation, neither EEE-50 (DC 4.51 ± 0.59, WC 4.51 ±
0.32 kcal· min-1) nor EEE-100 (DC 6.56 ± 0.60, WC 6.69 ± 0.42 kcal· min-1) were significantly different between groups
(p ≥ .05). There were no significant within or between group time effects for substrate utilization at rest or during
EEE-50 or EEE-100 (p ≥ .05). To our knowledge this is the first study to demonstrate that a relatively small daily
dosage of DC can significantly elevate REE. However, it does not impact steady state EEE or substrate utilization
in a group of athletically fit females.
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INTRODUCTION
Moderate dark chocolate (DC) consumption has been reported to promote arterial vasodilation
and cerebral blood flow, enhance oxygen and glucose delivery, and improve cognitive function
(21). It has also been shown to decrease fat deposition in adolescents (21), low density
lipoprotein (LDL) cholesterol, high sensitivity C-reactive proteins, and inflammation and
platelet aggregation (6, 12, 27). Contrary to contemporary thought, moderate DC consumption
has not been shown to be associated with obesity (10, 21).
Flavonoids, naturally occurring polyphenolic plant compounds, are an active component of
cocoa to which many of its health benefits are attributed (5). Most recently these health benefits
have specifically been attributed to its antioxidant properties stemming from the bioflavonoid
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(-)-epicatechin (8). Using a mouse model, (-)-epicatechin administration was observed to reduce
skeletal muscle fatigue, improve treadmill performance, and increase muscle capillary density
(18). These positive findings were supported by the recent work of Taub et al. (26) indicating
that sedentary middle-age subjects consuming 20 g· d-1 of DC (% not reported) for three months
demonstrated a significant reduction in markers of oxidative stress, improvement in
mitochondrial function, maximal oxygen uptake, and cycling power output. Likewise,
Cavarretta et al. (3) while employing a slightly different DC dosing strategy (85% DC, 40 g· d-1,
30 d) reported significant improvements in antioxidant power and markers of muscle damage
in elite soccer athletes.
These positive findings are intriguing and raise a question of optimal DC dosing. There is
accumulating evidence suggesting that the consumption/administration of flavonoids with
high total antioxidant capacity (TAC) may actually inhibit, rather than enhance, skeletal muscle
adaptations to exercise (7, 20). Consequently, it is quite plausible that a larger dose of DC may
actually exhibit a negative impact on physiological function, whereas a smaller dosage would
not.
While these recent reports indicate positive health and physiological exercise performance
benefits with the administration of (-)-epicatechin and (-)-epicatechin-rich cocoa products, no
studies have investigated the impact of DC consumption on resting and exercise metabolism.
Consequently, the purpose of this study was to investigate the influence of 70% DC
supplementation on energy metabolism at rest and also during two different intensities of
steady state exercise, in a group of recreationally fit/athletic females. In an effort to minimize
any potential inhibitory effect of DC consumption associated with an increase in TAC, we chose
to administer DC in the same 20 g· d-1 dosage as Taub et al. (26) but for a significantly shorter
duration of 30 d. It was hypothesized that 30 d of DC consumption would stimulate significant
increases in both resting and exercise energy expenditure.
METHODS
Participants
The study employed a blind, placebo-controlled design and was approved by the Institutional
Review Board for the use of Human Subjects in Research (IRB 03572-2017) and is fully in
accordance to the ethical standards of the International Journal of Exercise Science (17). Inclusion
criteria were non-smoking, normal weight females (body mass index 18.5-25 kg· m2), 18-30 years
of age, performing a minimum of 5 h· wk-1 of moderate- to high-intensity exercise. 18 subjects
completed the study and there were no reported adverse events. Subjects were instructed to
maintain their normal physical activity levels throughout the duration of the study.
Protocol
The preliminary/familiarization assessment required subjects to arrive to the laboratory 3-4
hours post-prandial and having refrained from intense exercise for 48-h prior. Upon arrival,
subjects completed an informed consent and physical activity and health history questionnaire,
and were assessed for resting measures of body weight, height, heart rate, and blood pressure.
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Resting energy expenditure (REE) was assessed via open-circuit indirect calorimetry (Vmax
Encore Metabolic Cart; Yorba Linda, CA). Flow volume and gas calibrations were performed
prior to each testing session according to the manufacturer’s instructions. Subjects removed their
shoes, assumed a supine position on an examination table, and a Plexiglas ventilated hood was
placed over their head. Expired gases were then assessed for ~30-min. The first 10-min allowed
the subject to acclimate to the test and reach a metabolic steady state. The REE was determined
from 10-min of steady state respiratory gas measurements assessed during min 10-30. During
this time, the flow pump rate was manipulated to insure a FECO2 between 0.75-0.85. Energy
expenditure was calculated as [3.941(VO2) + 1.106(VCO2)], where VO2 and VCO2 were reported
in L/min (29). Non-protein substrate utilization was calculated from respiratory quotient (RQ)
and VO2 (13).
Upon completion of the assessment of REE, the metabolic cart was immediately calibrated to
accommodate exercise testing, and the subject was fitted with a facemask and mass flow sensor.
The subject then performed 20-min of continuous exercise on a Velotron cycle (Racermate,
Seattle, WA) with the first 10-min performed at 50 watts and the last 10-min performed at 100
watts. Expired gas volumes and content were analyzed and used in the assessment of EEE and
substrate utilization. Cycling cadence was selected by each subject and then replicated during
subsequent sessions.
The pre-supplementation assessment was scheduled ~7-d after the preliminary/familiarization
assessment and ~14-d after the onset of their last menstrual cycle to control for fluctuations in
metabolic rate (24). Subjects then performed another assessment for REE and 20-min of cycling
with 10-min each at 50 and 100 watts. Upon completion of the second visit, each subject was
provided 14-d of supplementation.
The post-supplementation assessment was performed, as closely as possible, to the same day of
their menstrual cycle as performed during the pre-supplementation assessment. The postsupplementation assessment consisted of REE and EEE in the same fashion as described in the
pre-supplementation assessment.
Supplementation was assigned using a randomized, blind design. The experimental treatment
consisted of 20 g of 70% DC (Scharffen Berger Baking Chunks or Squares, The Hershey
Company, Hershey, PA) and the placebo consisted of a calorically matched (~100 kcal) volume
of WC (White Chocolate Baking Chips, The Hershey Company, Hershey, PA). Supplementation
duration was initially scheduled for a total of 28 days; however, in an effort to minimize the
influence of the menstrual cycle on metabolic rate, the duration was individualized for each
subject (24). An individual not affiliated with the project was responsible for the preparation of
the supplementation. Each day’s chocolate was individually wrapped in foil and placed into a
plastic bag with 7 days in each plastic bag for a total of 4-5 bags for each participant. These were
then placed in single brown paper bags to disguise the content from the investigators.
Additionally, subjects were informed that the purpose of the study was to investigate the effect
of chocolate on resting and exercise metabolism; however, they were blinded to the fact that DC
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was the treatment of interest and that the WC was the placebo. To our knowledge, there was no
communication between subjects.
Subjects were instructed to consume their prescribed chocolate and to return in 14-d to receive
the other 14-d of assigned supplementation. At this time subjects were questioned regarding
compliance with the supplement ingestion protocol and those unable, or unwilling, to comply
were excluded from further participation in the study. During the supplementation period,
subjects were instructed to refrain from the consumption of high flavonoid containing foods
such as extra chocolate, blueberry, cherry, strawberry, blackberry, raspberry, apple,
pomegranate fruits and/or products, chestnuts, hazelnuts, black tea, green tea, and red wine.
Additionally, subjects were instructed not to consume their prescribed chocolate within1-h
before or after consumption of any dairy product (i.e., yogurt, sour cream, milk, cottage cheese,
cheese, and butter/margarine). There are conflicting reports on the influence of dairy on the
bioavailability of flavonoids, so we chose a conservative approach to restrict dairy use with the
consumption of the chocolate (11, 22).
Statistical Analysis
Statistical analyses were performed using Statistical Packaging for the Social Sciences (SPSS). A
2 X 2 mixed design ANOVA (Treatment: WC vs. DC; Time: pre-supplementation vs. postsupplementation) was used to assess differences within and between conditions for REE, EEE,
and substrate oxidation rates. The significance level was set at p < .05. All data are presented as
mean ± SD.
RESULTS
Inclusion criteria were non-smoking, normal weight females (body mass index 18.5-25 kg· m2),
18-30 years of age, performing a minimum of 5 h· wk-1 of moderate- to high-intensity exercise.
Twenty-five subjects met the inclusion criteria; however, seven were eventually excluded due
to a variety factors such as non-compliance with supplementation/exercise, incurring a physical
injury during the course of the study that limited their ability to continue, and surprisingly a
dislike for chocolate. While subjects clearly understood that the study was investigating
chocolate, they were not aware that DC was the experimental treatment being investigated.
Subsequent to initiating the study, one subject expressed a dislike for the taste of the 70% DC
and voluntarily discontinued. This left a final subject pool of n = 18, (DC n = 9, WC n = 9).
Subjects reported no adverse health effects with supplementation. The duration of
supplementation for each group was not significantly different (DC 30.8 ± 2.6, WC 30.6 ± 4.2 d).
Subject characteristics are indicated in Table 1 and there were no significant differences between
groups.
Neither Pre-supplementation REE (DC 1448 ± 174, WC 1560 ± 155 kcal· d-1) or Postsupplementation REE (DC 1588 ± 248, WC 1557 ± 169 kcal· d-1) were significantly different
between groups (p ≥ .05). However, there was a significant treatment by time effect, with the
post supplementation mean REE significantly increased by 9.6% in DC (Δ REE: DC 140 ± 132,
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WC -3 ± 93 kcal· d-1, p = .017) with 7 of 9 subjects demonstrating an increase in REE. Group
effects and individual subject responses are shown in Figure 1.
Table 1. Subjects’ characteristics.
WC (n = 9)
DC (n = 9)
Body weight (kg)
69.4 ± 11.7
71.4 ± 11.8
Height (m)
1.71 ± 0.07
1.69 ± 0.7
BMI (kg· m2)
23.4 ± 2.2
25.0 ± 3.3
Age (yr)
21.1 ± 1.7
21.3 ± 1.9
Note. Values are expressed as mean ± SD. WC = White Chocolate; DC = Dark Chocolate.

p-value
.72
.83
.24
.80

Figure 1. Individual subjects REE pre- and post-supplementation with white chocolate or dark chocolate (•).
••• indicates mean data for each group. # indicates a between groups time effect with the dark chocolate pre-post
significantly greater than white chocolate pre-post (p = .017).

There were no significant interaction, time, or group effects for resting fat or carbohydrate
(CHO) substrate utilization during the assessment of REE (p > .05) (Table 2).
Table 2. Resting substrate utilization.
WC PRE
Fat (g· d-1)
108.7 ± 32.5
CHO (g· d-1)
128.2 ± 76.0
Note. Values are expressed as mean ± SD. WC
supplementation; POST = after supplementation.

WC POST
DC PRE
DC POST
99.6 ± 42.0
125.0 ± 36.6
107.1 ± 29.4
148.6 ± 107.1
63.7 ± 52.1
138.7 ± 74.3
= White Chocolate; DC = Dark Chocolate; PRE = before

There were no significant interaction, time, or group effects during the assessment of EEE at
cycling power outputs of both 50W (EEE-50) and 100W (EEE-100) (p > .05), VO2 at cycling power
outputs of both 50W (VO2-50) and 100W (VO2 -100) (p > .05), or RQ determined at cycling power
outputs of both 50W (RQ-50) and 100W (RQ-100) (p > .05) (Table 3).
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Table 3. Energy expenditure, oxygen uptake, and respiratory quotient during exercise.
WC PRE
WC POST
DC PRE
DC POST
-1
Exercise energy expenditure (kcal· min )
EEE-50
4.65 ± 0.56
4.51 ± 0.32
4.90 ± 0.33
4.52 ± 0.59
EEE-100
6.82 ± 0.53
6.69 ± 0.42
7.13 ± 0.45
6.56 ± 0.60
-1
Exercise oxygen uptake (L· min )
VO2-50
0.94 ± 0.11
0.91 ± 0.06
0.99 ± 0.07
0.91 ± 0.12
VO2-100
1.36 ± 0.11
1.34 ± 0.08
1.43 ± 0.09
1.31 ± 0.12
Respiratory Quotient (RQ)
RQ-50
0.91 ± 0.05
0.92 ± 0.05
0.91 ± 0.04
0.93 ± 0.04
RQ-100
0.97 ± 0.05
0.97 ± 0.05
0.96 ± 0.05
0.97 ± 0.04
Note. Values are expressed as mean ± SD. WC = White Chocolate; DC = Dark Chocolate; PRE = before
supplementation; POST = after supplementation; Exercise energy expenditure at cycling power outputs of 50W,
(EEE-50); and 100W, (EEE-100). Oxygen uptake at cycling power outputs of 50W (VO2-50) and 100W (VO2-100).
Respiratory quotient (RQ) at cycling power output of 50W (RQ-50) and 100W (RQ-100).

DISCUSSION
The purpose of this study was to investigate the influence of a relatively small dosage of 70%
DC (20 g· d-1; ~100 kcal) of short duration (~30-d) on REE and EEE at two different intensities of
steady state exercise in a group of recreationally fit/athletic females. The most notable finding
was that DC consumption increased daily REE by ~9.6% (+140 kcal· d-1); however, this change
was not observed in EEE at either of the two exercise intensities.
The specific mechanisms by which DC impacts physiological function have not been clearly
elucidated. Being that nutritional supplements are not closely regulated (28), the recommended
dosages are often at the discretion of the manufacturer and/or consumer, leading some to the
assumption that “if a little is good, more is better”. Thus, a major confounding factor in the
interpretation of the literature is that there is little consistency in the dosing used in nutritional
supplementation studies. A positive health benefit attributed to DC consumption is the strong
polyphenol qualities of the flavonoid (-)-epicatechin (7). However, accumulating evidence
suggests that flavonoids with high total antioxidant capacity (TAC) may actually inhibit, rather
than enhance, skeletal muscle adaptations to exercise (7, 20). Taub et al. (26) chose to supplement
subjects with 20 g· d-1 of DC based on their previous work indicating that this provided blood
(-)-epicatechin levels that elicited peak effects in cultured cells. It is quite plausible that a larger
dose of DC may actually exhibit a negative effect on physiological function, whereas a smaller
dosage would not. With this thought in consideration, we wanted to minimize any potential
inhibitory effect of DC associated with an increase in TAC and consequently chose to employ a
relatively small DC supplementation dosage (20 g· d-1) over a short time duration (30 d).
Whereas, an increase in TAC associated with DC consumption may potentially inhibit
physiological function, recent evidence suggests a mechanism whereby (-)-epicatechins can
significantly alter mitochondrial structure and stimulate mitochondrial biogenesis (14, 25). It has
been posited that (-)-epicatechins may bind to cell surface G protein-coupled estrogen receptors,
positively impacting metabolic control and also stimulating mitochondrial biogenesis (15, 16).
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Taub et. al. (26) recently demonstrated that a 3-month administration of 20 g· d-1 of
(-)-epicatechin-rich cocoa increased maximal oxygen uptake and cycling power output in a
group of sedentary, middle-aged (~50 yrs.) males and females. It was suggested that this
positive effect might be due to an improvement in mitochondrial efficiency in response to the
flavonoid, (-)-epicatechin, and indeed this notion was supported by their observed 140%
increase in citrate synthase activity, a marker of mitochondrial function (26). Earlier work in
isolated mouse muscle indicated that (-)-epicatechin by itself, or combined with exercise, can
also induce structural and metabolic changes in skeletal and cardiac muscle (18). In light of these
previous reports, while only speculative, our findings of a 9.6% increase in REE would suggest
significant changes in mitochondrial function likely did occur with the administration of a
relatively small (20 g· d-1) and brief (30 d) supplementation of 70% DC.
Previous studies of both high intensity interval training (9) and aerobic exercise training (23)
demonstrated 20% and 45% increases in skeletal muscle citrate synthase, and an approximate
10% increase in maximal oxygen uptake, respectively. Both of these exercise-induced measures
are significantly less than that demonstrated in sedentary adults after 3 months of DC
supplementation (26). In addition, positive markers of oxidative stress were significantly
improved with DC supplementation (26) in a magnitude quite similar to that observed with
chronic physical conditioning (19). Collectively, these data suggest that (-)-epicatechin rich DC
may influence bioenergetics in a magnitude similar to, or possibly even greater than, that
observed with physical conditioning.
As indicated previously, (-)-epicatechin alone, and in combination with exercise, promotes
structural and metabolic changes in mouse skeletal and cardiac muscles and endurance capacity
(18). In contrast, Copp et al. (4) reported that (-)-epicatechin administration had no impact on
resting oxygen uptake or exercise performance. While any explanation for the contrary findings
is just speculative, two thoughts come to mind: 1) Is there a species difference (mice vs. rats) in
the response to (-)-epicatechin administration? 2) Was the difference in (-)-epicatechin dosage
responsible for the different findings? The positive findings of Nogueira et al. (18) were in
response to an (-)-epicatechin administration of 2 mg· kg-1· d-1 for 15 d, whereas the absence of
positive findings reported by Copp et al. (4) were in response to an (-)-epicatechin
administration of 4 mg· kg-1· d-1 for 24 d. Considering the accumulating evidence suggesting
that a high TAC may actually inhibit skeletal muscle adaptations (7, 20), the conflicting exercise
performance findings are not surprising.
With regards to steady state EEE, we had conditionally hypothesized that if changes in REE
were observed in response to DC supplementation, similar changes would be observed during
steady state EEE. Surprisingly, this was not the case. While Taub et al. (26) employed a similar
DC dosage for 90 d and reported a 17% increase in maximal oxygen uptake and improved
cycling endurance to exhaustion, our protocol supplementation duration was only 30 d and
evaluated the metabolic response during steady state exercise, not maximal exercise
performance. In addition, the subjects assessed in our study were relatively young (~21 years),
recreationally fit/competitive females, whereas the subjects of Taub et al. (26) were middle aged
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(~49 years) and sedentary. Due to the difference between the exercise protocols, as well as the
difference between subject characteristics, the conflicting findings are not surprising.
One potential confounding factor with the interpretation of the findings of this study relates to
the differences in the caffeine content of the DC and the placebo (no caffeine). Caffeine
supplementation has been reported to increase REE by as much as 13% (1) which is in the range
observed in the present study. However, the dosage of caffeine that elicited this response far
exceeds that which would have been consumed with the DC in the present study. It is estimated
that 20 g of 70% DC contains a total of only 8.5 mg of caffeine which is dramatically less than 10
mg/kg that elicited the 13% change in REE. While it is possible that the effects reported may be
partly attributable to the action of caffeine, it is quite unlikely that this played a significant role.
Never-the-less, it is suggested that future investigations attempt to control for this variable.
In summary, to our knowledge this is the first study to demonstrate that a relatively small daily
dosage of DC can significantly elevate REE but does not impact steady state EEE. Future DC
supplementation studies are warranted investigating: 1) energy balance, weight control, and
body composition, 2) energy metabolism in sedentary vs. exercise trained males and females, 3)
energy metabolism of post-menopausal and aged females, and 4) exercise metabolism and
skeletal muscle performance in aged individuals with sarcopenia.
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